NEW YORK (GenomeWeb News) – Three research teams developing molecular breast cancer diagnostic technologies at US universities have been chosen as winners of a competition aimed at helping them develop business plans to commercialize their innovations.

At total of 10 teams were selected as winners of the Breast Cancer Startup Challenge, a competition funded and led by the Avon Foundation for Women and supported by the National Cancer Institute and the Center for Advancing Innovation, the Avon Foundation said yesterday.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The New York Times' George Johnson muses on cancer's roots in multicellularity.

The San Diego Union Tribune wonders whether Medicare is ready for personalized medicine.

Jun Wang, the chief executive of BGI, has stepped down.

In PNAS this week: human T cell editing with CRISPR, retrotransposons acting as insulators, and more.